Please provide your email address to receive an email when new articles are posted on . Autoimmune encephalitis can affect any network of the brain related to sleep and result in various sleep ...

A mum from London thought her “world was over” when her three-year-old son was diagnosed with a rare autoimmune disease which ...

Please provide your email address to receive an email when new articles are posted on . Early and short-term rituximab may be an option to treat patients with certain forms of autoimmune encephalitis, ...

“My year of unraveling” is how a despairing Christy Morrill described nightmarish months when his immune system hijacked his brain. What’s called autoimmune encephalitis attacks the organ that makes ...

BALTIMORE — The anti-interleukin-6 (IL-6) antibody drug tocilizumab shows efficacy in the treatment of patients with autoimmune limbic encephalitis (ALE) who do not respond to rituximab, new research ...

The severity of the condition often requires intensive care for prolonged periods, and relapses may occur with greater or lesser frequency depending upon the specific condition. However, early and ...

5-year-old Nathan Camargo had seizures at school before he was diagnosed with an autoimmune disorder Wendy Grossman Kantor is an award-winning journalist who has contributed to PEOPLE for over 20 ...

In autoimmune encephalitis, a rare but serious and sometimes life-threatening inflammation of the central nervous system, the body's own defenses are directed against the central nervous system. This ...

The patient received a diagnosis of myasthenia gravis (MG), then underwent a medical odyssey as physicians attempted to pin down the cause of his neurological symptoms. Myasthenia gravis (MG) and ...

Like humans, dogs can develop autoimmune encephalitis, and it’s common - mostly affecting smaller breeds and young adult dogs. Now scientists understand that humans and their canine companions share ...

Autoimmune encephalitis encompasses a group of inflammatory disorders in which pathogenic autoantibodies target neuronal cell-surface or synaptic proteins, leading to subacute cognitive impairment, ...